CityU’s new blood test technology for accurate detection of cancer cells

Press/Media: Press / Media

View graph of relations

Description

Groundbreaking technology that can accurately perform early screening for cancer cells and effectively monitor disease status has been successfully developed by a biomedical research team at City University of Hong Kong (CityU).

With an accuracy rate of over 90%, the new technology can deteffct cancer cells with as little as 4 ml of blood in no more than five minutes, allowing a patient to know his or her risk of cancer as soon as possible. The new technology can also monitor the effectiveness of drugs used for medical treatment. 

Developed from the “cell manipulation and test platform based on microfluidic chip technology,” the process can accurately identify tumour cells circulating in the blood. Without requiring patients to undergo surgery, the technology can detect tumours as small as 0.1mm in the early stages of cancer. 

Led by Professor Michael Yang Mengsu, Acting Dean of the Jockey Club College of Veterinary Medicine and Life Sciences and Yeung Kin Man Chair Professor at Biomedical Sciences at CityU, key members of the research team include Dr Henry Zou HengDr Edwin Yu Wai-kin and Dr Xu Tao, all Senior Research Associates in the Department of Biomedical Sciences at CityU. 

Also, Cellomics has earned the title of Hong Kong Rising Star from Deloitte China and received the Gold Award and the Outstanding Biotechnology Invention Award of Asia International Innovative Invention Award 2019 from Hong Kong Federation of Innovative Technologies and Manufacturing Industries.

Set up with the support of CityU in 2017, Cellomics has been granted funding and work space to convert research achievements into commercial products through CityU’s Technology Start-up Support Scheme for Universities and the Incu-Bio Programme of Hong Kong Science and Technology Parks.

Period19 Dec 2019 → 6 Jan 2020

Media coverage

TitleHK CityU’s develops cancer cell detection tech
DescriptionA biomedical research team at City University of Hong Kong (CityU) has successfully developed ground-breaking technology that can accurately perform early screening for cancer cells and effectively monitor disease status.

CityU licensed the newly developed technology to a start-up company set up by the research team. The products invented by the company have received accreditation from China’s National Medical Products Administration and will be awarded the CE marking certification of in vitro diagnostic devices from the European Union in February 2020.
Persons
Media name/outletOpenGov Asia
PlaceSingapore
Media typeWeb
Producer/AuthorAlita Sharon
Date6/01/20
Linkhttps://www.opengovasia.com/hk-cityus-develops-cancer-cell-detection-tech/
Title香港城大研發 癌症5分鐘快篩
Description香港城市大學團隊昨天宣布研發出以五分鐘完成癌症篩查的技術,準確率超過九成,是全球同類技術中最快的篩查方法,相信半年後可在香港應用。但這項技術只能協助發現有實體腫瘤類型的癌症,例如血癌就不能檢測到。
Persons
Media name/outlet聯合新聞網
PlaceTaiwan
Media typeWeb
Producer/Author李春
Date20/12/19
Linkhttps://udn.com/news/story/7332/4237742
TitleFive-minute cancer test arrives
DescriptionResearchers at City University have developed a screening technology that can assess a person's cancer risk with a blood test. It is the fastest test globally - being three to six months faster than conventional visual tests.
Persons
Media name/outletThe Standard
PlaceHong Kong
Media typeWeb
Date20/12/19
Linkhttps://www.thestandard.com.hk/section-news/section/4/214706/Five-minute-cancer-test-arrives
Title城大研發5分鐘血液監測癌細胞
Description香港城市大學生物醫學研究團隊,成功研發出精準癌症早期篩查和疾病監測的突破性技術。病人只須透過4毫升血液檢查,5分鐘後即可分選出癌細胞,準確率逾九成;原理技術為全球最快。這項新技術可讓病人盡快得知患癌風險,同時監測藥物在治療過程中的療效。城大已將此技術授權予由研究團隊成立的初創企業--晶准生物醫藥集團,產品已獲中國國家食品藥品監督管理總局(NMPA)認證,將於下月獲得歐盟體外診斷醫療器材(IVDD)CE認證。
Persons
Media name/outlet香港商報
PlaceHong Kong
Media typeWeb
Date20/12/19
Linkhttps://www.hkcd.com/content/2019-12/20/content_1170627.html
Title城大滴血驗癌 僅5分鐘料收費1萬
Description城市大學生物醫學研究團隊成功研發精準癌症血液檢測技術,只需抽取病人4毫升血液,5分鐘便可篩選出癌細胞,準確率逾9成,提升檢驗便利性,檢測速度是全球最快,更可最早於病發前3年檢測到癌細胞
Persons
Media name/outlet香港經濟日報
PlaceHong Kong
Media typeWeb
Date20/12/19
Linkhttps://paper.hket.com/article/2524411/%E5%9F%8E%E5%A4%A7%E6%BB%B4%E8%A1%80%E9%A9%97%E7%99%8C%20%E5%83%855%E5%88%86%E9%90%98%E6%96%99%E6%94%B6%E8%B2%BB1%E8%90%AC
Title4 毫升血可偵0.1 毫米腫瘤 微流控芯片技術精準 城大抽血驗癌 5分鐘「搞掂」
Description癌症早期篩查對病人健康以至整體醫療體系非常重要。香港城市大學生物醫學研究團隊昨日宣佈,成功研發出精準癌症早期篩查和疾病監測的突破性技術,該稱為「微流控芯檢查技術」,只需病人4毫升血液檢查,5分鐘後即可分選出癌細胞,準確率逾九成。城大已將此技術授權予由研究團隊成立的初創企業─晶准生物醫藥集團有限公司,其開發的產品已獲中國國家食品藥品監督管理總局(NMPA)認證,將於下月獲得歐盟體外診斷醫療器材(IVDD)CE認證,預計最快半年後可在本港市場推出應用,每次檢查費約1萬至1.5萬元。
Persons
Media name/outlet香港仔 Lion Rock Daily
PlaceHong Kong
Media typeWeb
Date20/12/19
Linkwww.lionrockdaily.com/2019/12/20/08.pdf
Title城大新技術 5分鐘驗癌九成準
Description香港城市大學生物醫學研究團隊研發出精準癌症早期篩查及疾病監測的突破性技術,只須透過4毫升血液檢查,5分鐘即可篩選出癌細胞,檢測速度全球最快,準確率更逾九成。即使是小至0.1毫米的腫瘤亦能及早發現,最早可於病發前3年檢測到癌症,更可監測藥物療效。
Persons
Media name/outlet信報財經新聞
PlaceHong Kong
Media typeWeb
Date20/12/19
Linkhttps://www1.hkej.com/dailynews/article/id/2334181/
Title香港研發出精準癌症血液檢測技術:5分鐘分選癌細胞準確率逾九成
Description香港城市大學生物醫學研究團隊19日宣佈,成功研發出精準癌症早期篩查和疾病監測的突破性技術,病人只需透過4毫升血液檢查,5分鐘後即可分選出癌細胞,準確率逾九成。這項新技術可讓病人盡快得知患癌風險,同時監測藥物在治療過程中的療效。由城大團隊研發的新技術,主要針對血液中的循環腫瘤細胞,可精準檢測癌細胞,小至0.1毫米的腫瘤亦能及早發現,而且全程以血液檢查,即液體活檢方式就能檢測,毋須進行手術抽取組織檢查。
Persons
Media name/outlet正報
PlaceMacao
Media typeWeb
Producer/Author黎金良
Date20/12/19
Linkwww.chengpou.com.mo/dailynews/183923.html
Title港研發出精準癌症血液檢測技術 五分鐘分選癌細胞準確率逾九成
Description香港城市大學生物醫學研究團隊十九日宣佈,成功研發出精準癌症早期篩查和疾病監測的突破性技術,病人只需透過四毫升血液檢查,五分鐘後即可分選出癌細胞,準確率逾九成。這項新技術可讓病人盡快得知患癌風險,同時監測藥物在治療過程中的療效。由城大團隊研發的新技術,主要針對血液中的循環腫瘤細胞,可精準檢測癌細胞,小至零點一毫米的腫瘤亦能及早發現,而且全程以血液檢查,即液體活檢方式就能檢測,毋須進行手術抽取組織檢查。
Persons
Media name/outlet華僑報
PlaceMacao
Media typeWeb
Producer/Author黎金良
Date20/12/19
Linkwww.vakiodaily.com/news/view/id/358315
Title城大研早期癌症篩檢 5分鐘知結果 準確率逾九成
Description香港城市大學生物醫學研究團隊以「微流控晶片細胞操控與檢測技術平台」,研發出癌症血液檢測技術,只需抽取約4毫升血液,約5分鐘可分辨出癌細胞,準確率逾九成,可用於早期癌症篩檢及監測藥物在治療過程中療效。研究團隊去年成立初創公司「晶准醫學」,並於今年第三季開發出分析儀,料最快半年後在港投入使用。
Persons
Media name/outlet明報
PlaceHong Kong
Media typeWeb
Date20/12/19
Linkhttps://news.mingpao.com/pns/%E6%B8%AF%E8%81%9E/article/20191220/s00002/1576780526432/%E5%9F%8E%E5%A4%A7%E7%A0%94%E6%97%A9%E6%9C%9F%E7%99%8C%E7%97%87%E7%AF%A9%E6%AA%A2-5%E5%88%86%E9%90%98%E7%9F%A5%E7%B5%90%E6%9E%9C-%E6%BA%96%E7%A2%BA%E7%8E%87%E9%80%BE%E4%B9%9D%E6%88%90
Title城大研發出5分鐘癌症檢測技術 準確率逾9成
Description城市大學團隊研發出以5分鐘完成癌症篩查的技術,只須抽取病人4毫升血液檢查,就可以得出患癌風險及藥物療效,準確率超過9成,是全球同類技術中最快的篩查方法;即使腫瘤只有0.1毫米,都可以驗出,較現有的影像檢測早3至6個月發現癌症,病人亦毋須做手術抽取組織化驗。

研究團隊指,這項技術的突破在於可以在血液中直接檢測到癌細胞存在,而非只是驗出癌症指標,而醫生通過有關技術,亦可監測癌症病人病情,以及檢視療效。
Persons
Media name/outletLINE TODAY
PlaceHong Kong
Media typeWeb
Date20/12/19
Linkhttps://today.line.me/hk/pc/article/%E5%9F%8E%E5%A4%A7%E7%A0%94%E7%99%BC%E5%87%BA5%E5%88%86%E9%90%98%E7%99%8C%E7%97%87%E6%AA%A2%E6%B8%AC%E6%8A%80%E8%A1%93%E3%80%80%E6%BA%96%E7%A2%BA%E7%8E%87%E9%80%BE9%E6%88%90-gP96oG
Title港城大研新技術 5分鐘快速檢測癌癥
Description香港城市大學團隊近期研發出以5分鐘完成癌癥篩查的技術,只須抽取病人4毫升血液檢查,就可以得出患癌風險及藥物療效,準確率超過9成,是全球同類技術中最快的篩選查方法;即使腫瘤只有0.1毫米,都可以驗出,較現有的影像檢測早3至6個月發現癌癥。

  研究團隊指,所有病人都適合接受這項檢查,過往不能動手術抽組織的病人,都可透過這項技術檢查癌細胞狀態,不過技術只能協助發現有實體腫瘤類型的癌癥,例如血癌就不能檢測到。研究團隊正與本港不同醫療機構及實驗室洽談協議,相信技術在半年後可在香港應用。
Persons
Media name/outlet香港新聞網
PlaceHong Kong
Media typeWeb
Date20/12/19
Linkwww.hkcna.hk/content/2019/1219/799906.shtml
Title癌症早筛新进展 香港城大研发出精准快速癌症血液检测技术
Description目前,癌症检测主要依靠影像检查及病理化验,早期癌症筛查难度较大。12月19日,香港城市大学生物医学研究团队宣布,研发出精准癌症早期筛查和疾病监测的突破性技术,有望通过抽取少量血液检查,快速分拣出癌细胞,检测速度全球最快,让患者尽快获知患癌风险。
Persons
Media name/outlet财新网
PlaceChina
Media typeWeb
Producer/Author文思敏
Date20/12/19
Linkwww.caixin.com/2019-12-20/101496127.html
Title城大研發5分鐘血液監測癌細胞
Description香港城市大學生物醫學研究團隊,成功研發出精準癌症早期篩查和疾病監測的突破性技術。病人只須透過4毫升血液檢查,5分鐘後即可分選出癌細胞,準確率逾九成;原理技術為全球最快。這項新技術可讓病人盡快得知患癌風險,同時監測藥物在治療過程中的療效。
 
  據介紹,現時要斷定病人是否患上癌症,常見的檢查方法包括影像檢測及以手術抽取病人腫瘤組織化驗,亦可測試血液當中腫瘤分泌出來的蛋白標記物,但相關技術的靈敏度和特異性一般只有五至六成,不屬於精準檢測。
Persons
Media name/outlet中國評論新聞網
PlaceHong Kong
Media typeWeb
Date20/12/19
Linkhk.crntt.com/doc/1056/3/8/5/105638548.html?coluid=0&kindid=0&docid=105638548&mdate=1220140636
Title癌症早筛新进展 香港城大研发出精准快速癌症血液检测技术
Description目前,癌症检测主要依靠影像检查及病理化验,早期癌症筛查难度较大。12月19日,香港城市大学生物医学研究团队宣布,研发出精准癌症早期筛查和疾病监测的突破性技术,有望通过抽取少量血液检查,快速分拣出癌细胞,检测速度全球最快,让患者尽快获知患癌风险。
Persons
Media name/outlet腾讯网
PlaceChina
Media typeWeb
Producer/Author文思敏
Date20/12/19
Linkhttps://new.qq.com/rain/a/20191220A0955500
Title城大新血液檢測 5分鐘揪出癌細胞
Description香港城市大學研究團隊成功研發精準癌症早期篩查技術,以及疾病監測技術,病人只需透過四毫升血液檢查,五分鐘後即可分選出癌細胞,原理技術為全球最快,準確率逾九成,讓病人盡快得知患癌風險,亦可監測藥物在治療過程中療效。城大已將技術授權予由研究團隊成立的初創企業,相信半年後可在港應用。
Persons
Media name/outlet東方日報
PlaceHong Kong
Media typeWeb
Date20/12/19
Linkhttps://orientaldaily.on.cc/cnt/news/20191220/mobile/odn-20191220-1220_00176_050.html
Title城大新驗血技術 5分鐘揪出癌細胞 準確度9成 病發前3年已檢測到
Description城大生物醫學研究團隊成功研發精準癌症血液檢測技術,只需抽取病人4毫升血液,5分鐘便可篩選出癌細胞,準確率逾9成,提升檢驗便利性,檢測速度是全球最快,更可最早於病發前3年檢測到癌細胞,小至0.1毫米腫瘤亦能發現,料最快半年後在港使用。惟腫瘤科專科醫生表示,「滴血驗癌」僅能作初步檢測,須進一步以影像和抽取組織化驗作檢查。
Persons
Media name/outlet晴報
PlaceHong Kong
Media typeWeb
Producer/Author李卓成
Date20/12/19
Linkhttps://skypost.ulifestyle.com.hk/article/2524449/%E5%9F%8E%E5%A4%A7%E6%96%B0%E9%A9%97%E8%A1%80%E6%8A%80%E8%A1%93%205%E5%88%86%E9%90%98%E6%8F%AA%E5%87%BA%E7%99%8C%E7%B4%B0%E8%83%9E%20%E6%BA%96%E7%A2%BA%E5%BA%A69%E6%88%90%20%E7%97%85%E7%99%BC%E5%89%8D3%E5%B9%B4%E5%B7%B2%E6%AA%A2%E6%B8%AC%E5%88%B0
Title城大研究新突破 準確度逾九成 四毫升血五分鐘驗出癌細胞
Description香港城市大學的生物醫學研究團隊,成功研發出精準癌症早期篩查和疾病監測的突破性技術,病人只需透過四毫升血液檢查,五分鐘後即可分選出癌細胞,準確度逾九成,讓病人盡快得知患癌風險,同時可監測藥物在治療過程中的療效。
Persons
Media name/outlet頭條日報
PlaceHong Kong
Media typeWeb
Date20/12/19
Linkhttps://hd.stheadline.com/news/daily/hk/821490/%E6%97%A5%E5%A0%B1-%E6%B8%AF%E8%81%9E-%E5%9F%8E%E5%A4%A7%E7%A0%94%E7%A9%B6%E6%96%B0%E7%AA%81%E7%A0%B4-%E6%BA%96%E7%A2%BA%E5%BA%A6%E9%80%BE%E4%B9%9D%E6%88%90-%E5%9B%9B%E6%AF%AB%E5%8D%87%E8%A1%80%E4%BA%94%E5%88%86%E9%90%98%E9%A9%97%E5%87%BA%E7%99%8C%E7%B4%B0%E8%83%9E
Title城大新癌症血液檢測技術 驗癌只需4毫升血5分鐘
Description現時判斷病人是否患上癌症,常見的檢查方法以影像檢測和腫瘤液體活檢法,惟方法耗時,準確率僅50%至60%;城大成功研發癌症血液檢測技術,病人不但只需透過4毫升血液,更可5分鐘後即可分辨出癌細胞,且準確率高達逾九成,亦能夠讓病人提早3至6個月發現癌症,及早治療。研發團隊稱現時正收集更多臨床測試結果,最快明年中內可於本港應用。
Persons
Media name/outletam730
PlaceHong Kong
Media typeWeb
Date20/12/19
Linkhttps://www.am730.com.hk/news/%E6%96%B0%E8%81%9E/%E5%9F%8E%E5%A4%A7%E6%96%B0%E7%99%8C%E7%97%87%E8%A1%80%E6%B6%B2%E6%AA%A2%E6%B8%AC%E6%8A%80%E8%A1%93-%E9%A9%97%E7%99%8C%E5%8F%AA%E9%9C%804%E6%AF%AB%E5%8D%87%E8%A1%805%E5%88%86%E9%90%98-201002
Title城大研微流控芯片 幾滴血五分鐘驗癌
Description癌症早期篩查對病人健康以至整體醫療體系非常重要,城市大學的研究團隊,成功研發出微流控芯片檢查技術,只需要病人4毫升血液,5分鐘後即可驗出癌細胞,準確率逾九成。團隊已就技術成立初創企業,計劃將之轉化為市場產品。
Persons
Media name/outlet文匯報
PlaceHong Kong
Media typeWeb
Producer/Author高鈺
Date20/12/19
Linkpaper.wenweipo.com/2019/12/20/HK1912200045.htm
TitleCityU research new technology about 10,000 yuan can draw blood to test early cancer as soon as six months later
DescriptionAt present, most patients in Hong Kong use tumor imaging and surgery to extract tumor tissues from patients for laboratory tests to detect cancer. The City University Biomedical Research Team announced today (19th) that a new detection technology has been developed. Cancer cells can be sorted in about five minutes. If the sample is found to contain 4 or more cancer cells, it means a greater chance of cancer. The team pointed out that the accuracy rate of detecting cancer cells can be as high as 90%, but the current stage of the examination failed to reflect the source of the cancer cells, that is, the source of the disease could not be found in the same examination.
Persons
Media name/outletThe Limited Times
Media typeWeb
Producer/AuthorDeng Yinglin
Date19/12/19
Linkhttps://newsrnd.com/news/2019-12-19--cityu-research-new-technology-about-10-000-yuan-can-draw-blood-to-test-early-cancer-as-soon-as-six-months-later.H1bzLidAS.html
TitleCityU’s new blood test technology for accurate detection of cancer cells
DescriptionGroundbreaking technology that can accurately perform early screening for cancer cells and effectively monitor disease status has been successfully developed by a biomedical research team at City University of Hong Kong (CityU).

With an accuracy rate of over 90%, the new technology can detect cancer cells with as little as 4 ml of blood in no more than five minutes, allowing a patient to know his or her risk of cancer as soon as possible. The new technology can also monitor the effectiveness of drugs used for medical treatment.

Developed from the “cell manipulation and test platform based on microfluidic chip technology,” the process can accurately identify tumour cells circulating in the blood. Without requiring patients to undergo surgery, the technology can detect tumours as small as 0.1mm in the early stages of cancer.

Led by Professor Michael Yang Mengsu, Acting Dean of the Jockey Club College of Veterinary Medicine and Life Sciences and Yeung Kin Man Chair Professor at Biomedical Sciences at CityU, key members of the research team include Dr Henry Zou Heng, Dr Edwin Yu Wai-kin and Dr Xu Tao, all Senior Research Associates in the Department of Biomedical Sciences at CityU.
Persons
Media name/outletCityU NewsCentre
PlaceHong Kong
Media typeWeb
Producer/AuthorKenix Wong
Date19/12/19
Linkhttps://www.cityu.edu.hk/media/news/2019/12/19/cityus-new-blood-test-technology-accurate-detection-cancer-cells
Title城大研新技術 約1萬元可抽血測早期癌症 最快半年後推出市場
Description現時本港多以影像檢測及手術抽取病人腫瘤組織化驗,來檢測癌症,城市大學生物醫學研究團隊今日(19日)公布,研發出新的檢測技術,只需抽取病人約4毫升血液,便可在約五分鐘內可分選出癌細胞,若樣本被發現含4個或以上癌細胞,即意味患癌機會較大。團隊指發現到癌細胞的準確率可高達9成,惟現階段檢查未能反映癌細胞源頭,即未能在同一檢查中找出病源。團隊已將技術化成儀器,並於今年第三季投產,料最快半年後可在本港市場上應用。
Persons
Media name/outlet香港01
PlaceHong Kong
Media typeWeb
Producer/Author鄧穎琳
Date19/12/19
Linkhttps://www.hk01.com/%E7%A4%BE%E6%9C%83%E6%96%B0%E8%81%9E/411746/%E5%9F%8E%E5%A4%A7%E7%A0%94%E6%96%B0%E6%8A%80%E8%A1%93-%E7%B4%841%E8%90%AC%E5%85%83%E5%8F%AF%E6%8A%BD%E8%A1%80%E6%B8%AC%E6%97%A9%E6%9C%9F%E7%99%8C%E7%97%87-%E6%9C%80%E5%BF%AB%E5%8D%8A%E5%B9%B4%E5%BE%8C%E6%8E%A8%E5%87%BA%E5%B8%82%E5%A0%B4
TitleCityU research collects blood to detect cancer with accuracy of 90%
DescriptionCancer is the number one killer in Hong Kong, and the number of new cases has been increasing year by year. The Cancer Data Statistics Centre of the Hospital Authority previously released 2017 cancer data. The number of new cases was as high as 33,075, a record high of at least 9 years. The current common method for detecting cancer is to use imaging or surgery to extract the patient's tumor tissue for laboratory tests. However, the Biomedical Research Team of the City University of Hong Kong announced today (19th) that a new detection technology has been developed and confirmed by clinical tests. With 4 ml of blood drawn, cancer cells can be sorted out within five minutes, and the accuracy rate is as high as 90%. Even the earliest (stage 1) cancer detection rate is higher than the industry, which is about 75%.
Persons
Media name/outletThe Limited Times
Media typeWeb
Producer/AuthorDeng Yinglin
Date19/12/19
Linkhttps://newsrnd.com/news/2019-12-19--cityu-research-collects-blood-to-detect-cancer-with-accuracy-of-90%25.SJsaFuO0H.html
Title城大研發驗癌新技術 抽血檢測僅需 5 分鐘全球最快
Description癌症是人類頭號殺手之一,如果能及早發現,成功康復的機會可更高。城市大學生物醫學研究團隊公布研發出新的檢測技術,只需抽取病人約 4 毫升血液,便可在約 5 分鐘內可分選出癌細胞,準確率逾 9 成。
Persons
Media name/outletezone
PlaceHong Kong
Media typeWeb
Producer/Author何兆洋
Date19/12/19
Linkhttps://ezone.ulifestyle.com.hk/article/2524305/%E5%9F%8E%E5%A4%A7%E7%A0%94%E7%99%BC%E9%A9%97%E7%99%8C%E6%96%B0%E6%8A%80%E8%A1%93%20%20%E6%8A%BD%E8%A1%80%E6%AA%A2%E6%B8%AC%E5%83%85%E9%9C%80%205%20%E5%88%86%E9%90%98%E5%85%A8%E7%90%83%E6%9C%80%E5%BF%AB
Title城大驗血測早期癌症技術 五分鐘有結果準確率逾九成
Description城市大學研發出新技術,可驗血檢測早期癌症,五分鐘有結果,準確率逾九成。

現時病人是否確診癌症,主要靠影像檢測及以手術抽取腫瘤組織化驗。近年推出驗血方法,但透過檢測腫瘤分泌的蛋白標記物,準確度只有五至六成。

城大生物醫學研究團隊研發新技術,直接檢測血液中的癌細胞,只需四毫升血液,五分鐘內有結果,0.1毫米的腫瘤亦能發現,準確率超過九成,較現有影像檢測可以提早三至六個月發現癌症,但不是適用於所有癌症。
Persons
Media name/outlet無綫新聞
PlaceHong Kong
Media typeWeb
Date19/12/19
Linknews.tvb.com/local/5dfb55e5335d19b254f664e3/%E5%9F%8E%E5%A4%A7%E9%A9%97%E8%A1%80%E6%B8%AC%E6%97%A9%E6%9C%9F%E7%99%8C%E7%97%87%E6%8A%80%E8%A1%93-%E4%BA%94%E5%88%86%E9%90%98%E6%9C%89%E7%B5%90%E6%9E%9C%E6%BA%96%E7%A2%BA%E7%8E%87%E9%80%BE%E4%B9%9D%E6%88%90
Title城大研發出5分鐘癌症檢測技術 準確率逾9成
Description城市大學團隊研發出以5分鐘完成癌症篩查的技術,只須抽取病人4毫升血液檢查,就可以得出患癌風險及藥物療效,準確率超過9成,是全球同類技術中最快的篩查方法;即使腫瘤只有0.1毫米,都可以驗出,較現有的影像檢測早3至6個月發現癌症,病人亦毋須做手術抽取組織化驗。

研究團隊指,這項技術的突破在於可以在血液中直接檢測到癌細胞存在,而非只是驗出癌症指標,而醫生通過有關技術,亦可監測癌症病人病情,以及檢視療效。
Persons
Media name/outlet商業電台
PlaceHong Kong
Media typeWeb
Date19/12/19
Linkhttps://www.881903.com/Page/ZH-TW/newsdetail.aspx?ItemId=1240357&csid=261_341